Adient price target lowered to $30 from $32 at Deutsche Bank

Deutsche Bank lowered the firm’s price target on Adient to $30 from $32 and keeps a Hold rating on the shares following the fiscal Q2 report. The company reset expectations in a challenging environment, the analyst tells investors in a research note.